Previous Article | Next Article 
Journal of Virology, May 2000, p. 4652-4657, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Successful Vaccine-Induced Seroconversion by
Single-Dose Immunization in the Presence of Measles Virus-Specific
Maternal Antibodies
Bernd
Schlereth,1
John K.
Rose,2
Linda
Buonocore,2
Volker
ter Meulen,1 and
Stefan
Niewiesk1,*
Institute of Virology and Immunobiology,
University of Wuerzburg, 97078 Wurzburg,
Germany,1 and Departments of
Pathology and Cell Biology, Yale University School of Medicine, New
Haven, Connecticut 065102
Received 13 December 1999/Accepted 14 February 2000
In humans, maternal antibodies inhibit successful immunization
against measles, because they interfere with vaccine-induced seroconversion. We have investigated this problem using the cotton rat
model (Sigmodon hispidus). As in humans, passively
transferred antibodies inhibit the induction of measles virus
(MV)-neutralizing antibodies and protection after immunization with MV.
In contrast, a recombinant vesicular stomatitis virus (VSV) expressing
the MV hemagglutinin (VSV-H) induces high titers of neutralizing
antibodies to MV in the presence of MV-specific antibodies. The
induction of neutralizing antibodies increased with increasing virus
dose, and all doses gave good protection from subsequent challenge with MV. Induction of antibodies by VSV-H was observed in the presence of
passively transferred human or cotton rat antibodies, which were used
as the models of maternal antibodies. Because MV hemagglutinin is not a
functional part of the VSV-H envelope, MV-specific antibodies only
slightly inhibit VSV-H replication in vitro. This dissociation of
function and antigenicity is probably key to the induction of a
neutralizing antibody in the presence of a maternal antibody.
*
Corresponding author. Mailing address: Institut
für Virologie und Immunbiologie, Versbacher Str. 7, 97078 Würzburg, Germany. Phone: 49 931 201 3441. Fax: 49 931 201 3934. E-mail: niewiesk{at}vim.uni-wuerzburg.de.
Journal of Virology, May 2000, p. 4652-4657, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., Birungi, J., Pozniak, A., McPhee, D. A., Manigart, O., Karita, E., Inwoley, A., Jaoko, W., DeHovitz, J., Bekker, L.-G., Pitisuttithum, P., Paris, R., Walker, L. M., Poignard, P., Wrin, T., Fast, P. E., Burton, D. R., Koff, W. C.
(2009). Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm. J. Virol.
83: 7337-7348
[Abstract]
[Full Text]
-
Pasetti, M. F., Ramirez, K., Resendiz-Albor, A., Ulmer, J., Barry, E. M., Levine, M. M.
(2009). Sindbis Virus-Based Measles DNA Vaccines Protect Cotton Rats against Respiratory Measles: Relevance of Antibodies, Mucosal and Systemic Antibody-Secreting Cells, Memory B Cells, and Th1-Type Cytokines as Correlates of Immunity. J. Virol.
83: 2789-2794
[Abstract]
[Full Text]
-
Peng, Y., Lin, F.-c., Verardi, P. H., Jones, L. A., Yilma, T. D.
(2009). Lower Levels of Gamma Interferon Expressed by a Pseudotyped Single-Cycle Simian Immunodeficiency Virus Enhance Immunogenicity in Rats. J. Virol.
83: 1592-1601
[Abstract]
[Full Text]
-
Cooper, D., Wright, K. J., Calderon, P. C., Guo, M., Nasar, F., Johnson, J. E., Coleman, J. W., Lee, M., Kotash, C., Yurgelonis, I., Natuk, R. J., Hendry, R. M., Udem, S. A., Clarke, D. K.
(2008). Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice. J. Virol.
82: 207-219
[Abstract]
[Full Text]
-
Pueschel, K., Tietz, A., Carsillo, M., Steward, M., Niewiesk, S.
(2007). Measles Virus-Specific CD4 T-Cell Activity Does Not Correlate with Protection against Lung Infection or Viral Clearance. J. Virol.
81: 8571-8578
[Abstract]
[Full Text]
-
Brandsma, J. L., Shylankevich, M., Su, Y., Roberts, A., Rose, J. K., Zelterman, D., Buonocore, L.
(2007). Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus. J. Virol.
81: 5749-5758
[Abstract]
[Full Text]
-
Ramsburg, E. A., Publicover, J. M., Coppock, D., Rose, J. K.
(2007). Requirement for CD4 T Cell Help in Maintenance of Memory CD8 T Cell Responses Is Epitope Dependent. J. Immunol.
178: 6350-6358
[Abstract]
[Full Text]
-
Simon, I. D., Publicover, J., Rose, J. K.
(2007). Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA. J. Virol.
81: 2078-2082
[Abstract]
[Full Text]
-
Kohl, W., Grone, A., Moennig, V., Herrler, G.
(2007). Expression of the surface glycoprotein E2 of Bovine viral diarrhea virus by recombinant vesicular stomatitis virus. J. Gen. Virol.
88: 157-165
[Abstract]
[Full Text]
-
Natuk, R. J., Cooper, D., Guo, M., Calderon, P., Wright, K. J., Nasar, F., Witko, S., Pawlyk, D., Lee, M., DeStefano, J., Tummolo, D., Abramovitz, A. S., Gangolli, S., Kalyan, N., Clarke, D. K., Hendry, R. M., Eldridge, J. H., Udem, S. A., Kowalski, J.
(2006). Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4+ Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge. J. Virol.
80: 4447-4457
[Abstract]
[Full Text]
-
Ramsburg, E., Publicover, J., Buonocore, L., Poholek, A., Robek, M., Palin, A., Rose, J. K.
(2005). A Vesicular Stomatitis Virus Recombinant Expressing Granulocyte-Macrophage Colony-Stimulating Factor Induces Enhanced T-Cell Responses and Is Highly Attenuated for Replication in Animals. J. Virol.
79: 15043-15053
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Rose, J. K.
(2005). A Single-Cycle Vaccine Vector Based on Vesicular Stomatitis Virus Can Induce Immune Responses Comparable to Those Generated by a Replication-Competent Vector. J. Virol.
79: 13231-13238
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Rose, J. K.
(2004). Characterization of Nonpathogenic, Live, Viral Vaccine Vectors Inducing Potent Cellular Immune Responses. J. Virol.
78: 9317-9324
[Abstract]
[Full Text]
-
Roberts, A., Reuter, J. D., Wilson, J. H., Baldwin, S., Rose, J. K.
(2004). Complete Protection from Papillomavirus Challenge after a Single Vaccination with a Vesicular Stomatitis Virus Vector Expressing High Levels of L1 Protein. J. Virol.
78: 3196-3199
[Abstract]
[Full Text]
-
Schlereth, B., Buonocore, L., Tietz, A., Meulen, V. t., Rose, J. K., Niewiesk, S.
(2003). Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose. J. Gen. Virol.
84: 2145-2151
[Abstract]
[Full Text]
-
Pasetti, M. F., Barry, E. M., Losonsky, G., Singh, M., Medina-Moreno, S. M., Polo, J. M., Ulmer, J., Robinson, H., Sztein, M. B., Levine, M. M.
(2003). Attenuated Salmonella enterica Serovar Typhi and Shigella flexneri 2a Strains Mucosally Deliver DNA Vaccines Encoding Measles Virus Hemagglutinin, Inducing Specific Immune Responses and Protection in Cotton Rats. J. Virol.
77: 5209-5217
[Abstract]
[Full Text]
-
Gundel, I., Weidinger, G., ter Meulen, V., Heesemann, J., Russmann, H., Niewiesk, S.
(2003). Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis. J. Gen. Virol.
84: 775-779
[Abstract]
[Full Text]
-
Ezelle, H. J., Markovic, D., Barber, G. N.
(2002). Generation of Hepatitis C Virus-Like Particles by Use of a Recombinant Vesicular Stomatitis Virus Vector. J. Virol.
76: 12325-12334
[Abstract]
[Full Text]
-
Buonocore, L., Blight, K. J., Rice, C. M., Rose, J. K.
(2002). Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins. J. Virol.
76: 6865-6872
[Abstract]
[Full Text]
-
Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E., Rose, J. K.
(2002). High-Level Primary CD8+ T-Cell Response to Human Immunodeficiency Virus Type 1 Gag and Env Generated by Vaccination with Recombinant Vesicular Stomatitis Viruses. J. Virol.
76: 2730-2738
[Abstract]
[Full Text]
-
Kahn, J. S., Roberts, A., Weibel, C., Buonocore, L., Rose, J. K.
(2001). Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge. J. Virol.
75: 11079-11087
[Abstract]
[Full Text]
-
Skiadopoulos, M. H., Surman, S. R., Riggs, J. M., Collins, P. L., Murphy, B. R.
(2001). A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys. J. Virol.
75: 10498-10504
[Abstract]
[Full Text]
-
von Messling, V., Zimmer, G., Herrler, G., Haas, L., Cattaneo, R.
(2001). The Hemagglutinin of Canine Distemper Virus Determines Tropism and Cytopathogenicity. J. Virol.
75: 6418-6427
[Abstract]
[Full Text]
-
Rose, N. F., Roberts, A., Buonocore, L., Rose, J. K.
(2000). Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1. J. Virol.
74: 10903-10910
[Abstract]
[Full Text]